Display options
Share it on

Value Health. 2014 Nov;17(7):A431. doi: 10.1016/j.jval.2014.08.1098. Epub 2014 Oct 26.

Global HTA Assessments of Ultra-Orphan Products: A Case Study Of Eculizumab (Soliris) and Iduronate-2-Sulfatase (Elaprase).

Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research

A Paul, J Morawski, D S Spinner, J J Doyle, E C Faulkner, J F Ransom

Affiliations

  1. Quintiles Consulting, Durham, NC, USA.
  2. Quintiles, Cambridge, MA, USA.
  3. Quintiles, Durham, NC, USA.
  4. Quintiles, Hawthorne, NY, USA.
  5. Institute for Pharmacogenomics and Individualized Therapy, Eshelman School of Pharmacy, University of North Carolina, Chapel Hill, NC, USA.
  6. Quintiles Global Consulting, Hawthorne, NY, USA.

PMID: 27201127 DOI: 10.1016/j.jval.2014.08.1098

[No abstract available.]

Publication Types